In this paper we report exploratory analyses of high-density oligonucleotide array data from the Affymetrix GeneChip R system with the objective of improving upon currently used measures of gene expression.
Introduction
High density oligonucleotide expression array technology is now widely used in many areas of biomedical research. The system (Lockhart et al. (1996) ) uses oligonucleotides with length of 25 base pairs that are used to probe genes. Typically each gene will be represented by 16-20 pairs of oligonucleotides referred to as probe sets. The first component of these pairs is referred to as a perfect match (PM) probe. Each PM probe is paired with a mismatch (MM) probe that is created by changing the middle (13th) base with the intention of measuring non-specific binding. The PM and MM are referred to as a probe pair. See the Affymetrix Microarray Suite User Guide (1999) for details. RNA samples are prepared, labeled and hybridized with arrays. Arrays are scanned and images are produced and analyzed to obtain an intensity value for each probe.
These intensities represent how much hybridization occurred for each oligonucleotide probe. Of interest is finding a way to combine the 16-20 probe pair intensities for a given gene to define a measure of expression that represent the amount of the corresponding mRNA species.
We denote the intensities obtained for each probe as PM i jn and MM i jn , i = 1, . . . , I, j = 1, . . . , J n , and n = 1, . . . , N with n representing the different genes, i representing different RNA samples, and j representing the probe pair number (this number is related to the physical position of the oligonucleotide in the gene). The number of genes N usually ranges from 8,000 to 20,000, the number of arrays I ranges from 1 to hundreds, and the number of probe pairs within each gene J n usually ranges from 16 to 20. Throughout the text indexes are suppressed when there is no ambiguity.
Section 2 describes the three data sets used in this paper. Section 3 explores various interesting features of the data with the objective of defining an effective measure of gene expression using the probe level data. Section 4 describes normalization. Some expression measures, for example AvDiff and Li and Wong's MBEI, are based on PM − MM. Other measures, for example Affymetrix's Average Log Ratio, are based on log(PM/MM). In Sections 3 and 4 we also explore the behavior of these quantities. Section 5 describes four measures of expression. Section 6 assesses the four expression measures in terms of bias, variance, and model fit. Section 7 examines the ability of the four methods at detecting differentially expressed probe sets.
Section 8 presents our conclusions.
Description of Data
To properly compare summary measures of expression in terms of bias, variance, sensitivity, and specificity, data for which we know the "truth" is required. In this paper we examine three data sets for which assessments can be performed where specific results are expected. Data set A provides probes for which we can assume the measurements are entirely due to non-specific binding. This permits us to study the variance-mean relationship for intensity measures. Data set B provides the results of a spike-in experiment where gene fragments have been added at known concentrations. These data can be used to assess bias, sensitivity and specificity. Data set C provides the results from a study in which samples were hybridized at different dilutions. This permits us to assess bias and variance in a more "realistic" scenario than with data set B.
Data sets B and C are available from the web at http://qolotus02.genelogic.com/datasets.nsf/.
In this section we describe them in detail for readers interested in using them. We also explain which specific subsets of the data were used for the analyses presented in this paper.
Mouse Data Set -A
Data set A comes from an experiment where five MG-U74A mouse GeneChip R arrays were used. These were hybridized with samples of lung tissue mRNA obtained from five mice exposed to different experimental conditions. About 1/5 of the probe pairs in the MG-U74A array were incorrectly sequenced. We therefore assume that the measurements read for most of these probes are entirely due to non-specific binding.
Spike-In Data Sets -B
Data set B consists of experiments where 11 different cRNA fragments were added to the hybridization mixture of the GeneChip R arrays at different picomolar (pM) concentrations. The 11 control cRNAs were , CreX-5, CreX-3 (phage P1), and DapX-5, DapX-M, DapX-3 (B. subtilis) (Hill et al., 2000; Hill et al., 2001; Baugh et al., 2001) . The cRNA were chosen to match the target sequence for each of the Affymetrix control probe sets. For example, for DapX (a B. subtilis gene), the 5', middle and 3' target sequences (identified by DapX-5, DapX-M, DapX-3) were each synthesized separately and spiked-in at a specific concentration. Thus, for example, on one of the arrays DapX-3 target sequence was added to the total hybridization solution of 200 µl to give a final concentration of 0.5 pM.
There are 2 series of spike-in experiments. The experiments were originally carried out for the development of normalization procedures . In this paper we use the data in a different way, mainly for the comparison of expression measures.
The varying concentration series data set -B1
For an individual array, all of the 11 control cRNAs were spiked-in at the same concentration and this concentration was varied across arrays, taking the values 0.0, 0.5, 0.75, 1, 1.5, 2, 3, 5, 12.5, 25, 50, and 150 pM.
For example, array 1 had all control cRNAs spiked with 0.0 pM and array 2 had all control cRNAs spiked with 0.5 pM, etc.. Of these 12 concentrations, 0, 0.5, 0.75, 1, 1.5, 2, 3 were represented on just 1 array, 5
and 100 on 2 arrays, and the rest were in triplicate, i.e. on 3 arrays for a total of 27 arrays. All arrays have a common background cRNA from an acute myeloid leukemia (AML) tumor cell line. In this paper we use only 12 arrays, one replicate for each of the 12 concentrations. One of the probe set spike-in combinations (CreX-3) failed to respond adequately, and data from that probe set is entirely omitted from the analysis.
Thus we analyze data from 10 spiked-in probe-sets.
Latin square series data set -B2
In this series each of the 11 control cRNAs were spiked-in at a different concentration on each array (apart from replicates). The 12 concentrations used were 0.5, 1, 1.5, 2, 3, 5, 12.5, 25, 37.5, 50, 75 , and 100 pM, and these were arranged in a 12x12 cyclic Latin square, with each concentration appearing once in each row and column. The 12 combinations of concentrations used on the arrays were taken from the first 11 entries of the 12 rows of this Latin square. Of the 12 combinations used, 11 were done on 3 arrays and 1 on just one array.
All of these arrays had the same AML background as in data set B1.
The analysis in this paper makes use of data from six arrays that are a pair of triplicates. The spike-in concentrations for each of the 11 control RNAs on the two sets of triplicates is shown in Table 1 . Notice that relative concentrations of the spike-ins are 3-fold or more, which permits us to check the sensitivity of expression indexes.
Dilution Data Set -C
Two sources of cRNA. A (human liver tissue) and B (Central Nervous System cell line) were hybridized to human array (HG-U95A) in a range of proportions and dilutions. In this publication, we study data from arrays hybridized to source A starting with 1.25 µg cRNA, and rising through 2.5, 5.0, 7.5, 10.0 to 20.0 µg.
There were five replicate arrays for each tissue; that is each generated cRNA was hybridized on 5 HG-U95 GeneChip R arrays. Five scanners were used in this study. Each array replicate was processed in a different scanner. Figure 1a shows histograms of log ratio, log 2 (PM/MM), stratified by quantiles of abundance, log 2
Features of probe level data
with gray scale representing height of histogram (light is high and dark is low) for one array from data set A.
The histograms have been scaled so that the mode of each histogram is represented with the same gray scale.
This figure shows that, in general, MM grows with PM. Furthermore, for larger values of abundance the differences have a bimodal distribution with the second mode occurring for negative differences. The same bimodal effect is seen when we stratify by log 2 (PM), thus it is not an artifact of conditioning on sums. In 
are computed for a random sample of 2000 defective probe sets, the SD increases from roughly 50 to 5000, a factor of 100 fold, as the average increases on its entire range. After a log transformation of the PM intensities there is only a 1.5 fold increase.
Normalization
In many of the applications of high density oligonucleotide arrays, the goal is to learn how RNA populations differ in expression in response to genetic and environmental differences. For example, large expression of a particular gene or genes may cause an illness resulting in variation between diseased and normal tissue.
These sources of variation are referred to as interesting variation. Observed expression levels also include variation introduced during the sample preparation, manufacture of the arrays, and the processing of the arrays (labeling, hybridization, and scanning). These are referred to as sources of "obscuring variation". See Figures 3a and 3b show log ratios, M = log 2 (y/x) versus abundance A = log 2 √ x × y, (MVA) plots for
for two arrays (denoted with 1 and 2) in which the BioDn-3 gene has been spiked at 5 pM and 2 pM respectively. These plots have been used by, for example, Dudoit et al. (2001) to explore intensity related biases. Because the same RNA background was hybridized to arrays 1 and 2, we do not expect any of the non-spiked-in genes to be differentially expressed and therefore these plots to scatter around 0. It is clear from Figure 3 that these data need normalization.
For cDNA arrays the normalization procedure presented in Dudoit et al. (2001) has worked well in practice. For each array, a loess curve is fitted to the MVA plot of intensities of the red and green labels and the residuals are considered the normalized log ratios. However, this approach is not appropriate for GeneChip R arrays because only one sample is hybridized to each array instead of two (red and green). A procedure that normalizes each array against all others is needed.
Various methods have been proposed for normalizing GeneChip R arrays. Bolstad et al. (2002) present a review of these methods and find quantile normalization to perform best. The goal of quantile normalization is to make the distribution of probe intensities the same for arrays i = 1, . . . , I. The normalization maps probe level data from all arrays, i = 1, . . . , I, so that an I-dimensional quantile-quantile plot follows the Idimensional identity line. A possible problem with this approach is that we risk removing some of the signal in the tails. However, empirical evidence suggest this is not a problem in practice; see Bolstad et al. (2002) for details.
In Figure 3c We have observed that linear scale measures, such as AvDiff, are not optimal. Li and Wong (2001a) observed this and proposed an alternative model based expression index. For each probe set n, Li and Wong's measure is defined as the maximum likelihood estimates of the θ i , i = 1, . . . , I obtained from fitting
with φ j representing probe-specific affinities and the ε i jn s are assumed to be independent normally distributed errors. The estimation procedure includes rules for outlier removal. Figure 4c , the additive probe-specific effect is also detected by the MM motivating their subtraction from the PM. However, in Figure 4d the parallel lines are still seen in PM − MM, demonstrating that subtracting is not enough to remove the probe effect. The fact that parallel lines are not as obvious in Figure 4c shows that dividing by MM removes, to some degree, the probe effect. However, the MM also grow Figure 4 , the logscale slope of the PM is less than 1, particularly for small concentrations, the PM values should be adjusted to account for non-specific binding. To see this consider a hypothetical case with two arrays where the signal of a probe set is twice as big in one of the arrays, but an additive signal of 100 units occurs due to non-specific binding and/or background noise in both arrays. In this case the observed difference in the signals would be about log 2 (100 + 2s) − log 2 (100 + s) instead of log 2 (2s) − log 2 (s). For small values of s the incorrect difference would be close to 0 instead of 1. Figure 5 shows histograms of log 2 (MM) for an array in which no probe-set was spiked along with the 3 arrays in which BioB-5 was spiked-in at concentrations of 0.5, 0.75, and 1 pM (from data set B1). All arrays in all data sets had similar shaped log 2 (MM) histograms. Furthermore, the log 2 (MM) histograms for the To obtain an expression measure we assume that for each probe set n, the background adjusted, normalized, and log transformed PM intensities, denoted with Y , follow a linear additive model
with α j a probe affinity effect, µ i representing the log scale expression level for array i, and ε i j representing an independent identically distributed error term with mean 0. For identifiability of the parameters we assume that ∑ j α j = 0 for all probe sets. This assumption is saying that Affymetrix technology has chosen probes with intensities that on average are representative of the associated genes expression. The estimate of µ i gives the expression measures for probe set n on array i.
To summarize, in this paper we consider a new expression measure that i) background corrects the arrays using the transformation B(·), ii) normalizes the arrays using quantile normalization, and iii) for each probe set n, fits a linear model (2) to the background corrected, normalized and log (base 2) transformed probe intensities denoted here with Y i j , i = 1, . . . , I, j = 1, . . . , J. To protect against outlier probes we use a robust procedure, such as median polish (Holder et al., 2001 ), to estimate model parameters. We use the estimate of µ i as the log scale measure of expression which we refer to as robust multi-array average (RMA).
Bias, variance, and goodness of fit comparisons
Plots of log observed expression versus known concentration (not shown) demonstrate that the expression measures perform similarly in detecting the spiked-in probe sets. However, for the highest concentration, AvDiff and MBEI sometimes underestimate the predicted value from the known concentrations. This results from the attenuation caused by subtracting MM. We also notice that RMA is less noisy than all other measures at lower concentrations.
It is possible that the control genes used in data set B1 provide a stronger than usual signal. Therefore, a comparison based on all probe sets of the HG-U95A arrays is conducted using data set C. For these data the amount of hybridization of probe sets representing expressed genes is expected to double when the amount of RNA hybridized to the array is double. Furthermore, the difference in gene expression across replicate arrays should be small. Figure 6b shows loess curves fitted to the scatter plot (on the log scale) of SD i vs E i· .
Clearly, RMA has the smallest SD across replicates. The advantage of RMA is especially noticeable in the low expression values where the SD is 10 times smaller than the other measures.
Li and Wong's method provides not only an estimate of θ i but a nominal SE for this estimate, denoted here withσ i . Under (2) one can obtain a naive nominal estimate for the SE ofμ using an analysis of variance approach. Because there are 5 replicates one can also obtain an observed SE of any estimate by simply considering the SD i defined above. If the model is close to the actual mechanism giving rise to the data, the nominal and observed SE should agree. Plots of nominal to observed SE log ratios versus expression (not shown) show that in general, RMA is closer to 0 than Li and Wong's MBEI showing that the observed and nominal standard error methods are, in general, closer when using (2) instead of (1).
Detection of differential expression
Data set 2B was used to assess how well the different expression measures perform at detecting differentially expressed probe sets. For each of the six arrays studied expression measures
were obtained in their respective scale (log for MAS 5.0 and RMA) for each probe set n = 1, . . . , N. We then computed the averages over triplicates
For the probe sets representing spike-in RNAs the observed ratios or "fold changes" (E 2·n /E 1·n for AvDiff and MBEI or 2 E 1·n −E 2·n for MAS 5.0 and RMA) should coincide with the true ratio of the spike-in concentrations shown in Table   1 . Recall that apart from the spiked-in probe sets, the background samples hybridized to the six arrays are the same. We therefore expect only the 11 probe sets shown in Table 1 probe-sets. In the right side of Figure 7 , quantile-quantile plots of the observed ratios are shown. RMA is the only measure to perfectly differentiate the spiked-in probe sets (with the exception BioC-3, which no measure was able to detect) from the rest. Table 1 shows the observed rank of the spiked-in probe sets.
Conclusion
In this paper we have developed a novel measure of gene expression and compared it to other standard measures. Through the analyses of three data sets, we have shown that expression is better measured using log transformed PM values, after carrying out a global background adjustment and across array normalization.
We studied the performance of a version of the Affymetrix summary measures AvDiff and MAS 5.0, the Li and Wong model-based expression index, and the new measure RMA. We evaluated the four expression summary measures using spike-in and dilution study data, assessing their behavior in terms of bias, variance, the ability to detect known differential expression levels, and (for MBEI and RMA) model fit. We conclude that there is no obvious downside to summarizing the expression level of a probe set with RMA, and attaching an SE to this quantity using a linear model that removes probe-specific affinities. The greater sensitivity and specificity of RMA in detection of differential expression provides a useful improvement for researchers using the GeneChip R technology. We expect marginal though worthwhile gains to be achievable by using a more carefully designed and tested background correction procedure.
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